Quintiles Library

promo_digital_graphs
Featured Video

Predictive and Advanced Analytics
Sr. VP of Data Sciences & Strategy Margaret Keegan discusses how new Predictive and Advanced Analytics provides identification of potential patient safety issues and actionable insight into clinical trial site performance. ...
Show Filters
Video
Laura Marquis, Vice President & Global Head of Emerging Biopharma at Quintiles, discusses the strategic importance and growing role emerging biopharmas are playing in the global biopharmaceutical market, and how Quintiles is adapting to meet their unique...
Fact Sheet
A Clinical Evaluation Report (CER) is a living document required for the EU market for all classes of new and existing devices, detailing the clinical evaluation of a product throughout its life-cycle.  Whilst the requirement to have a CER is not new, it is subject to more intense scrutiny by Notified Bodies in the conformity assessment phase, and CERs are increasingly being assessed in the post-market...
Read More
Fact Sheet
Infographic featuring development of vaccines with an emphasis on the clinical trial aspect of that...
Read More
Video
With rapid advances in genomic technologies, today their value extends beyond the discovery phase of drug research. Here, Dr. Patrick Hurban explains how to select the right genomic technology to gain the right insights that successfully advance research and development...
Fact Sheet
Business domain expertise is critical to the success of IT projects. Leverage Quintiles’ deep IT and clinical domain expertise to develop, build and operate IT systems and services tailored to meet your...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. and MADISON, N.J. – July 2, 2015 – Quintiles and Quest Diagnostics today announced the launch of Q2 Solutions, their new combined clinical trials laboratory services organization. Q2 Solutions brings together the clinical trials laboratory operations of the two parent organizations to provide biopharmaceutical customers with the diverse capabilities and end-to-end services required in the rapidly evolving biopharmaceutical industry. Today’s launch of Q2 Solutions is the result of the close of the previously announced global clinical trials laboratory services joint-venture transaction. Q2 Solutions is strongly positioned as the second-largest central laboratory services company in the world and provides services to customers across all segments of the...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – July 1, 2015 – Quintiles Transnational Holdings Inc. (NYSE: Q) will release its second-quarter 2015 financial results Wednesday, July 29, 2015 prior to its quarterly earnings call at 8:00 a.m. EDT. The conference call will be accessible, live via webcast, on the Investor Relations section of the Quintiles website at www.quintiles.com/investors. To participate via telephone, please dial +1 (855) 710-5091 in the United States or +1 (706) 902-0591 outside the United States, approximately 15 minutes before the scheduled start of the call. An archived edition of the conference call will be available online at www.quintiles.com/investors after 1:00 p.m. EDT on Wednesday, July 29th. About Quintiles Quintiles (NYSE: Q) helps biopharma and other healthcare...
Read More
White Paper
This insight brief explores the benefits of Model-based Drug Development (MBDD) for emerging biopharma companies. MBDD is the process of leveraging modeling and simulation throughout the project life cycle to predict trial results and inform planning and design decisions. MBDD is a proven and often effective method for reducing the costly delays and changes that plague typical development efforts by enabling project teams to select the right dose, estimate patient recruitment, and optimize protocol, study and program...
Explore More
Fact Sheet
Historically, lifecycle management (LCM) has been focused primarily on market expansion and product life extension. However in today’s rapidly changing healthcare environment, this is no longer enough. You must also focus on product protection and differentiation as strategies for delivering real value to all stakeholders in the healthcare system. At Quintiles, we believe in order for your product to succeed in the changing health landscape, you must implement an integrated lifecycle management strategy that meets payer...
Read More
Fact Sheet
Understanding the needs of local payers is more important than ever for biopharma. It can be challenging to uncover the key requirements of a local market, and even more difficult to prove how a drug can help fulfill the unmet needs of the local population. With payers becoming more sophisticated in their evidentiary needs, Clinical Commissioning Groups (CCGs) now require data that is tailored to their local healthcare economy. The data generated needs to go beyond regulatory approval; it needs to prove cost effectiveness, provide checkpoints between payer and biopharma, and ensure the removal of any uncertainties that may result in barriers to market access. Quintiles has a network of strong local market access teams to help support you in reaching local decision makers and...
Read More